These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5331928)

  • 21. [Combination of 10 mg amitriptyline and 4 mg perphenazine: its value in dermatology].
    Allart JC
    Lille Med; 1977 Nov; 22(9 Suppl 2):746-8. PubMed ID: 609321
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of a protriptyline-perphenazine combination in chronic psychiatric patients.
    St-Jean A; Ban TA; Scott J
    Curr Ther Res Clin Exp; 1966 Oct; 8(10):483-6. PubMed ID: 4961168
    [No Abstract]   [Full Text] [Related]  

  • 23. ETRAFON IN REGRESSED SCHIZOPHRENIC PATIENTS.
    CHEN CH; HOLSTEIN AP; PRASAD PS
    Curr Ther Res Clin Exp; 1965 May; 7():318-9. PubMed ID: 14286213
    [No Abstract]   [Full Text] [Related]  

  • 24. Biphasic drugs in the treatment of depression with anxiety.
    Krakowski AJ
    Psychosomatics; 1969; 10(3):7-11. PubMed ID: 5822699
    [No Abstract]   [Full Text] [Related]  

  • 25. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R; Wegener G
    Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined amitriptyline-perphenazine (Etrafon) compared with chlordiazepoxide hydrochloride: a double-blind, crossover study.
    Martins JK
    Curr Ther Res Clin Exp; 1966 Jan; 8(1):17-22. PubMed ID: 4955142
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic trial of Mutanxion and Mutaspline in psychiatry].
    Mouren P; Giudicelli S; Scarrone JJ; D'omezon G
    Mars Med; 1971; 108(3):243-5. PubMed ID: 5576123
    [No Abstract]   [Full Text] [Related]  

  • 28. Gas chromatographic determination of amitriptyline, nortriptyline and perphenazine in plasma of schizophrenic patients after administration of the combination of amitriptyline with perphenazine.
    Cooper S; Albert JM; Dugal R; Bertrand M; Elie R
    Arzneimittelforschung; 1979; 29(1):158-61. PubMed ID: 582110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacologic combinations in the therapy of depression: experiences with Mutabon (perphenazine and amitriptyline)].
    Invernizzi G; Sostero M; Vitali A; Campanella F
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Dec; 95(6):1143-81. PubMed ID: 5143725
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical observations on reserpine reversal after prolonged MAO inhibition.
    Esser AH
    Psychiatr Neurol Neurochir; 1967; 70(1):59-63. PubMed ID: 5339995
    [No Abstract]   [Full Text] [Related]  

  • 32. Treating psychical disturbances induced by physical disorders: a double-blind study of perphenazine-amitriptyline in anxiety and depression.
    Davis WG
    Psychosomatics; 1968; 9(1):44-6. PubMed ID: 4867598
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
    [No Abstract]   [Full Text] [Related]  

  • 34. Simultaneous dissolution profiles of two drugs, sulfadiazine-trimethoprim and amitriptyline-perphenazine, in solid oral dosage forms by a FIA manifold provided with a single spectrophotometric detector.
    Gálvez AM; Mateo JV; Martínez Calatayud J
    J Pharm Biomed Anal; 2002 Oct; 30(3):535-45. PubMed ID: 12367678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amitriptyline-perphenazine in the treatment of schizophrenia.
    KENNEDY RE; MILLER JJ
    Am J Psychiatry; 1963 May; 119():1092-3. PubMed ID: 14031956
    [No Abstract]   [Full Text] [Related]  

  • 36. [Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses].
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):57-8. PubMed ID: 4907391
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data.
    Takeuchi H; Fervaha G; Uchida H; Suzuki T; Bies RR; Grönte D; Remington G
    J Clin Psychiatry; 2014 May; 75(5):506-11. PubMed ID: 24569099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. THE COMPARATIVE EFFECTIVENESS OF AMITRIPTYLINE, PERPHENAZINE, AND THEIR COMBINATION IN THE TREATMENT OF CHRONIC PSYCHOTIC FEMALE PATIENTS.
    HANLON TE; NUSSBAUM K; WITTIG B; HANLON DD; KURLAND AA
    J New Drugs; 1964; 4(1):52-60. PubMed ID: 14157086
    [No Abstract]   [Full Text] [Related]  

  • 39. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new method for treating "headaches".
    Sherwin D
    Am J Psychiatry; 1979 Sep; 136(9):1181-3. PubMed ID: 474806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.